On December 13, 2023, Prelude Therapeutics Incorporated closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 USD | -1.57% |
|
-4.58% | -12.18% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.18% | 209M | |
+18.09% | 45.51B | |
-9.42% | 38.52B | |
+38.08% | 38.13B | |
+26.35% | 30.74B | |
-8.64% | 26.03B | |
+12.04% | 25.92B | |
+46.56% | 14.13B | |
+33.53% | 12.73B | |
-7.37% | 11.29B |
- Stock Market
- Equities
- PRLD Stock
- News Prelude Therapeutics Incorporated
- Prelude Therapeutics Incorporated announced that it has received $24.999997 million in funding